Those Who Invested in Halozyme Therapeutics (NASDAQ:HALO) Five Years Ago Are up 159%

Simply Wall StDec 20 18:57

HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $68 Price Target

BenzingaDec 18 19:16 · Ratings

Johnson & Johnson Says Injectable Rybrevant Rejected by FDA

Seeking AlphaDec 17 19:48

How Much Upside Is Left in Halozyme Therapeutics (HALO)? Wall Street Analysts Think 27.08%

Yahoo FinanceDec 16 22:55

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This Is How Much It'd Be Worth Now

Zacks Dec 16 20:35

(HALO) - Analyzing Halozyme Therapeutics's Short Interest

BenzingaDec 12 02:45